A122
De-identified Human Immune Atlas donor/sample detail for Neutrophil_LiverCancer_Nature_2022. The record preserves available public metadata while avoiding direct identifiers.
Primary Metadata
Core de-identified metadata fields migrated from the ImmuneAging donor manifest.
Donor ID
A122
Sample ID
A122_HCC, A122_HCC_B, A122_HCC_N
Dataset
Neutrophil_LiverCancer_Nature_2022
Cohort
Human liver cancer cohort, 124 patients
Age / Age Group
65 years
Sex
Female
Health Status
Hepatocellular carcinoma (HCC); TNM I; BCLC A
Tissue / Cell Source
tumor tissue; peripheral blood; adjacent liver tissue
Modality
scRNA-seq
Cell Count
16,611
Analysis Status
Published scRNA-seq
UMAP Status
Ready
Metadata / Source Notes
Source: Nature Supplementary Table 1a/1b; patient samples: A122_HCC, A122_HCC_B, A122_HCC_N; library samples: A122_HCC, A122_HCC_B, A122_HCC_N; no. PB samples: 1; no. adjacent liver samples: 1; no. tumor samples: 1; differentiation: Low; venous invasion: 0; cirrhosis: 1
Additional Clinical / Source Fields
Supplementary source metadata retained from the migrated manifest where available.
cancer type
Hepatocellular carcinoma
cancer type short
HCC
tnm stage
I
bclc stage
A
virus
HBV
tumor size cm
1.5*3.5
differentiation
Low
venous invasion
0
cirrhosis
1
afp ug l
1210
ca199 u ml
60.95
cea ug l
3.97
library count
3
library sample ids
A122_HCC, A122_HCC_B, A122_HCC_N
total reads
1198290897
source reference
Xue et al., Nature 612, 141-147 (2022), Supplementary Table 1
data accession
PRJCA007744
article url